Discovery and development of integrase inhibitors - Wikipedia
Recent Advances in the Development of Integrase Inhibitors for HIV Treatment | SpringerLink
The discovery of allyltyrosine based tripeptides as selective inhibitors of the HIV-1 integrase strand-transfer reaction - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C6OB00950F
Elvitegravir - an overview | ScienceDirect Topics
Vitekta (Elvitegravir Tablets): Uses, Dosage, Side Effects, Interactions, Warning
Raltegravir: molecular basis of its mechanism of action | European Journal of Medical Research | Full Text
Elvitegravir
FDA approved Integrase strand transfer inhibitors INSTIs: raltegravir,... | Download Scientific Diagram
FDA-approved HIV integrase inhibitors (Raltegravir, Elvitegravir,... | Download Scientific Diagram
Elvitegravir - LiverTox - NCBI Bookshelf
FDA-approved integrase inhibitors : Raltegravir 1, Elvitegravir 2,... | Download Scientific Diagram
Update and latest advances in antiretroviral therapy: Trends in Pharmacological Sciences
Elvitegravir
Viruses | Free Full-Text | Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs | HTML
Frontiers | Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach | Chemistry
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised ...
Frontiers | Different Pathways Leading to Integrase Inhibitors Resistance | Microbiology
Integrase Inhibitors Raltegravir and Elvitegravir for HIV Disease
Comparative Study of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate, Each with Elvitegravir, Cobicistat, and Emtricitabine, for HIV Treatment
Elvitegravir
Discovery and development of integrase inhibitors - Wikipedia
